- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07685132
Correlation Between Carbapenemase-Producing Enterobacterales Load, Environmental Contamination, and Transmission in Critical Care Units (CPE-Load ICU S)
Carbapenemase-producing Enterobacterales (CPE) are multidrug-resistant bacteria that can colonize the gastrointestinal tract of hospitalized patients and spread within intensive care units (ICUs). Some colonized individuals may carry a particularly high bacterial burden and contribute disproportionately to environmental contamination and transmission to other patients. Identifying these high-risk individuals could improve infection prevention and control strategies.
This prospective observational study will be conducted in the Adult Intensive Care Unit of Hospital Italiano de Buenos Aires. Patients identified as colonized with CPE through routine surveillance will undergo quantitative culture and real-time polymerase chain reaction (PCR) testing of rectal swabs to measure bacterial load. Environmental samples will also be collected from high-touch surfaces surrounding colonized patients. In selected cases, molecular typing methods will be used to evaluate genetic relatedness between patient and environmental isolates and to investigate possible transmission events.
The primary objective is to determine the correlation between bacterial load measured by culture and the PCR cycle threshold (Ct) value. Secondary objectives include evaluating the association between bacterial load and environmental contamination, and assessing whether patients with higher bacterial loads are more likely to contribute to transmission within the ICU. Results may help identify patients with increased dissemination potential and support targeted infection prevention interventions.
Descripción general del estudio
Estado
Descripción detallada
Carbapenemase-producing Enterobacterales (CPE) represent a major global public health threat because of their extensive antimicrobial resistance and their ability to spread within healthcare facilities. Gastrointestinal colonization is recognized as the main reservoir for transmission. Previous studies have suggested that a subset of colonized patients, often referred to as "super-spreaders," carry a substantially higher bacterial burden and may account for a disproportionate share of environmental contamination and transmission events.
Although bacterial load can be quantified using culture-based and molecular methods, there is currently no validated cycle threshold (Ct) value from routinely used real-time PCR assays that reliably identifies patients with high dissemination potential. Establishing a correlation between Ct values and bacterial burden could provide a practical and accessible tool for infection prevention programs.
This prospective observational cohort study will be conducted in the Adult Intensive Care Unit of Hospital Italiano de Buenos Aires. All patients identified through the institutional surveillance program as colonized with CPE will be eligible for inclusion. For each CPE-positive patient, rectal swabs obtained as part of routine surveillance will undergo quantitative culture on selective chromogenic media and molecular testing using real-time PCR targeting carbapenemase genes. Bacterial load will be estimated using colony-forming unit counts and PCR Ct values.
Environmental contamination will be assessed through systematic sampling of high-touch surfaces in the patient's surroundings, including bed linen, bedside furniture, and medical equipment. Environmental isolates will undergo microbiological and molecular characterization. In selected situations, whole genome sequencing or pulsed-field gel electrophoresis will be performed to evaluate genetic relatedness among isolates recovered from patients, environmental samples, and secondary cases.
The primary outcome is the correlation between quantitative bacterial load and PCR Ct values. Secondary outcomes include the extent of environmental contamination associated with different bacterial loads and the occurrence of transmission events involving genetically related strains. Multivariable analyses will evaluate the influence of relevant clinical and epidemiological factors, including length of stay, fecal incontinence, prior antimicrobial exposure, immunosuppression, and other potential confounders.
The study involves minimal risk because all patient samples are obtained within the framework of routine infection control surveillance. Findings from this study may improve the identification of patients with increased transmission potential and support more targeted and efficient infection prevention strategies in critical care settings.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Maria Ines Staneloni, MD
- Número de teléfono: 8165 / 9542 +549 011 49590200
- Correo electrónico: maria.staneloni@hospitalitaliano.org.ar
Copia de seguridad de contactos de estudio
- Nombre: Emilio Felipe Huaier Arriazu, MD
- Número de teléfono: 8206 +549 011 49590200
- Correo electrónico: emilio.huaier@hospitalitaliano.org.ar
Ubicaciones de estudio
-
-
Buenos Aires F.D.
-
Buenos Aires, Buenos Aires F.D., Argentina, 1199
- Hospital Italiano de Buenos Aires
-
Contacto:
- Emilio Felipe Huaier Arriazu, MD
- Número de teléfono: 8165 / 9542 +549 011-49590200
- Correo electrónico: emilio.huaier@hospitalitaliano.org.ar
-
Contacto:
- CCI Comité de Control de Infecciones, MD
- Número de teléfono: 8165 / 9542 +54911-49590200
- Correo electrónico: comite.infecciones@hospitalitaliano.org.ar
-
Investigador principal:
- Maria Ines Staneloni, MD
-
Sub-Investigador:
- Emilio Felipe Huaier Arriazu, MD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria
- Age 18 years or older.
- Hospitalized in the Adult Intensive Care Unit of Hospital Italiano de Buenos Aires during the study period.
- Positive surveillance rectal swab for carbapenemase-producing Enterobacterales.
Exclusion Criteria
-Patients colonized or infected with carbapenemase-producing Enterobacterales who remained in the same room for less than 48 hours.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
CPE-Colonized ICU Patients
Patients admitted to the Adult Intensive Care Unit of Hospital Italiano de Buenos Aires with a positive surveillance rectal swab for carbapenemase-producing Enterobacterales (CPE).
Participants will undergo quantitative culture and real-time PCR testing of rectal swabs as part of routine surveillance.
Environmental samples will be collected from high-touch surfaces surrounding colonized patients to evaluate environmental contamination and transmission dynamics.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Correlation Between PCR Cycle Threshold (Ct) Value and Quantitative Bacterial Load (CFU/swab) in Rectal Surveillance Swabs
Periodo de tiempo: At baseline (time of positive rectal surveillance swab)
|
Spearman correlation coefficient between the cycle threshold (Ct) value obtained by real-time PCR (BD MAX™ system) targeting carbapenemase genes and the quantitative bacterial load measured by culture on CHROMagar™ KPC selective medium, expressed as colony-forming units per swab (CFU/swab), from rectal surveillance swabs positive for carbapenemase-producing Enterobacterales.
|
At baseline (time of positive rectal surveillance swab)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Correlation Between Quantitative Bacterial Load (CFU/swab) in Rectal Swabs and Number of CPE-Positive High-Touch Environmental Surfaces
Periodo de tiempo: Within 24 hours of rectal swab collection
|
Spearman correlation coefficient between the quantitative bacterial load of carbapenemase-producing Enterobacterales in rectal surveillance swabs, measured by culture on CHROMagar™ KPC selective medium and expressed as colony-forming units per swab (CFU/swab), and the number of CPE-positive high-touch surfaces out of 5 sampled (bed linen, bedside table, and infusion pump), assessed by quantitative culture on CHROMagar™ KPC contact plates.
|
Within 24 hours of rectal swab collection
|
|
Correlation Between PCR Cycle Threshold (Ct) Value in Rectal Swabs and Number of CPE-Positive High-Touch Environmental Surfaces
Periodo de tiempo: Within 24 hours of rectal swab collection
|
Spearman correlation coefficient between the cycle threshold (Ct) value obtained by real-time PCR (BD MAX™ system) targeting carbapenemase genes from rectal surveillance swabs positive for carbapenemase-producing Enterobacterales, and the number of CPE-positive high-touch surfaces out of 5 sampled (bed linen, bedside table, and infusion pump), assessed by quantitative culture on CHROMagar™ KPC contact plates.
|
Within 24 hours of rectal swab collection
|
|
Correlation Between Quantitative Bacterial Load (CFU/swab) in Rectal Swabs and Total Colony-Forming Units Recovered from Environmental Surfaces
Periodo de tiempo: Within 24 hours of rectal swab collection
|
Spearman correlation coefficient between the quantitative bacterial load of carbapenemase-producing Enterobacterales in rectal surveillance swabs, measured by culture on CHROMagar™ KPC selective medium and expressed as colony-forming units per swab (CFU/swab), and the total colony-forming units (CFU) recovered across five high-touch surfaces (bed linen, bedside table, and infusion pump) surrounding colonized patients, assessed by quantitative culture on CHROMagar™ KPC contact plates.
|
Within 24 hours of rectal swab collection
|
|
Correlation Between PCR Cycle Threshold (Ct) Value in Rectal Swabs and Total Colony-Forming Units Recovered from Environmental Surfaces
Periodo de tiempo: Within 24 hours of rectal swab collection
|
Spearman correlation coefficient between the cycle threshold (Ct) value obtained by real-time PCR (BD MAX™ system) targeting carbapenemase genes from rectal surveillance swabs positive for carbapenemase-producing Enterobacterales, and the total colony-forming units (CFU) recovered across five high-touch surfaces (bed linen, bedside table, and infusion pump) surrounding colonized patients, assessed by quantitative culture on CHROMagar™ KPC contact plates.
|
Within 24 hours of rectal swab collection
|
|
Number of Index Patients with Transmission of at Least One Genetically Related CPE Strain to a Co-Hospitalized Patient
Periodo de tiempo: Up to 6 months
|
Number of index patients associated with at least one secondary case carrying a genetically related carbapenemase-producing Enterobacterales strain, confirmed by whole genome sequencing (WGS) and/or pulsed-field gel electrophoresis (PFGE), among patients hospitalized in the same intensive care unit during the study period.
|
Up to 6 months
|
|
Number of Patients Meeting Predefined Criteria for Super-Spreader Classification
Periodo de tiempo: At baseline (time of CPE detection and environmental sampling)
|
Number of CPE-colonized patients classified as potential super-spreaders, defined post-hoc as having a cycle threshold (Ct) value below the 25th percentile of the study population and at least 2 positive environmental surfaces with more than 50 colony-forming units (CFU) each, assessed by quantitative culture on CHROMagar™ KPC contact plates.
|
At baseline (time of CPE detection and environmental sampling)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Maria Ines Staneloni, MD, Hospital Italiano de Buenos Aires
Publicaciones y enlaces útiles
Publicaciones Generales
- Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995 Sep;33(9):2233-9. doi: 10.1128/jcm.33.9.2233-2239.1995. No abstract available.
- Gomez SA, Pasteran FG, Faccone D, Tijet N, Rapoport M, Lucero C, Lastovetska O, Albornoz E, Galas M; KPC Group; Melano RG, Corso A, Petroni A. Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina. Clin Microbiol Infect. 2011 Oct;17(10):1520-4. doi: 10.1111/j.1469-0691.2011.03600.x. Epub 2011 Aug 18.
- Wei M, Chen X, Liu J, Li T, Wang P, Wang S, Wang J, Gu L. Development and Validation of a Novel Multiplex Real-Time PCR Assay for Rapid Detection of Carbapenemase Genes in Carbapenem-Resistant Enterobacterales Isolates and Clinical Samples. Infect Drug Resist. 2024 Aug 9;17:3451-3462. doi: 10.2147/IDR.S475630. eCollection 2024.
- Lerner A, Romano J, Chmelnitsky I, Navon-Venezia S, Edgar R, Carmeli Y. Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2013 Mar;57(3):1474-9. doi: 10.1128/AAC.01275-12. Epub 2013 Jan 7.
- Lerner A, Adler A, Abu-Hanna J, Cohen Percia S, Kazma Matalon M, Carmeli Y. Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration. Clin Microbiol Infect. 2015 May;21(5):470.e1-7. doi: 10.1016/j.cmi.2014.12.015. Epub 2014 Dec 26.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 7703 (CTEP)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Individual participant data underlying the results reported in publications will be available after de-identification. Data may be shared with qualified researchers upon reasonable request to the principal investigator and after approval by the Hospital Italiano de Buenos Aires Ethics Committee, in accordance with institutional policies and applicable regulations regarding data protection and patient confidentiality.
What IPD Will Be Shared? De-identified demographic data Clinical characteristics Rectal swab quantitative culture results PCR cycle threshold (Ct) values Environmental sampling results Molecular characterization and genomic data used in analyses Derived study variables
Marco de tiempo para compartir IPD
Criterios de acceso compartido de IPD
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- CÓDIGO_ANALÍTICO
- RSC
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .